- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02202018
A Cluster Randomized Trial to Assess the Impact of Patient and Provider Education on Use of Home Dialysis
Patient and Provider Education for Patients With Severe Chronic Kidney Disease: Assessing the Impact on Barriers and Use of Home Dialysis
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Background: Patients with severe kidney failure require dialysis or transplantation to survive. For those in whom a transplant is not an option, there are two main dialysis options: hemodialysis (either incenter or at home) or home peritoneal dialysis. Home-based therapies (peritoneal and home hemodialysis) are under-utilized in many Canadian jurisdictions with the proportion of home-based therapies varying between 10 and 40% across centres. The use of home dialysis remains lower than expected due to combination of patient, caregiver, provider, and health system barriers. Previous studies have highlighted several potential patient and caregiver barriers to use of home therapies including knowledge, skills, personal circumstances, and social supports. Provider barriers have been reported to include lack of training in peritoneal dialysis, lack (or perceived lack) in skills and knowledge, bias, and possibly inadequate physician reimbursement for home dialysis.
The Canadian Kidney Knowledge Translation and Generation Network (CANN-NET), a national network of clinicians, researchers and knowledge users that was established to ensure best practices for patients with chronic kidney disease (CKD), recently created dialysis modality educational tools aimed at patients and kidney health care providers. On behalf of CANN-NET, the investigators propose a cluster randomized controlled trial (with clusters consisting of severe CKD clinics) of a knowledge translation (KT) strategy to increase use of home dialysis in patients with end-stage renal disease. Informed by careful survey work, clinics randomized to the knowledge translation intervention will receive patient and provider directed educational tools, including the MATCH D tool, compelling visual aids (infographic, white board animated video, and an educational video on dialysis modality options), audit and feedback, and in-person medical detailing. Control clinics will continue with their usual practice with respect to dialysis modality education.
Primary Objective To determine whether a standardized modality education program directed at patients, in combination with provider-directed interventions can increase the use of home dialysis in incident dialysis patients in Canada
Study Design: A cluster randomized trial of CKD clinics across Canada comparing the efficacy and safety of a KT intervention aiming to increase use of home dialysis in patients with advanced CKD. The unit of observation will be the patient (i.e., outcomes will be measured at the level of an individual patient), and the unit of randomization will be at the level of the multidisciplinary CKD clinic.
Team: The investigative study team includes experts in the clinical epidemiology of CKD and kidney failure, local opinion leaders from every province/region, as well experts in knowledge translation and cluster randomized design. As such, the investigators are well positioned to carry out the proposed study.
Research Significance: Home dialysis, in comparison to incenter hemodialysis, is associated with increased patient independence, better clinical outcomes, and lower health care costs. Due to a variety of factors, home dialysis use remains variable across Canada. This study will test the effectiveness of a KT strategy to increase the use of home dialysis.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4Z6
- University of Calgary
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3T 2N2
- University of Manitoba
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Multidisciplinary clinics in Canada that provide care coordinated by a Nephrologist to patients with chronic kidney disease (CKD). These clinics have already been identified in a previous survey
Exclusion Criteria:
-
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Active KT Intervention
CKD clinics receiving the active knowledge translation intervention.
|
|
|
Geen tussenkomst: Usual standard of care
Clinics will continue their standard of care education and approach to use of home dialysis.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Primary Efficacy Outcome: Use of home dialysis
Tijdsspanne: Use of home dialysis at six months after dialysis initiation
|
Proportion of patients with incident end-stage renal disease initiating dialysis after the intervention who are using home dialysis (home hemodialysis or peritoneal dialysis) six months after dialysis initiation.
Use of home dialysis will be ascertained from the clinic clusters and confirmed by linkage with the Canadian Organ Replacement Register (CORR).
|
Use of home dialysis at six months after dialysis initiation
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Secondary outcome: Use of home dialysis at six months in patients who have been followed by a Nephrologist
Tijdsspanne: Use of home dialysis at six months after dialysis initiation in patients who have been followed by a Nephrologist
|
Proportion of patients with incident end-stage renal disease initiating dialysis after the intervention who were followed by a Nephrologist prior to dialysis initiation who are using home dialysis (home hemodialysis or peritoneal dialysis) six months after dialysis initiation.
Use of home dialysis will be ascertained from the clinic clusters and confirmed by linkage with the Canadian Organ Replacement Register (CORR).
|
Use of home dialysis at six months after dialysis initiation in patients who have been followed by a Nephrologist
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Braden Manns, MD, University of Calgary
- Studie directeur: Navdeep Tangri, MD PhD FRCPC, University of Manitoba
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- REB13-0083_MOD1
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Chronische nierziekte
-
Zhen LiAanmelden op uitnodigingGelijktijdige pancreas-kidney transplantatieChina
-
Third Affiliated Hospital, Sun Yat-Sen UniversityActief, niet wervendAcute-on-chronic leverfalen (ACLF)China
-
CHU de ReimsNog niet aan het wervenVloeistofresponsiviteit in de vroege post-kidney transplantatieperiodeFrankrijk
-
University Hospital, Basel, SwitzerlandNog niet aan het wervenCardiovasculair-kidney-metabool syndroom | Cradiovascular-Kidney-Liver-Metabolic (CKLM) syndroomZwitserland
-
Chung Shan Medical UniversityNational Science and Technology Council, TaiwanNog niet aan het wervenObesitas Type 2 Diabetes Mellitus | Metabole disfunctie-geassocieerde steatotische leverziekte | Cardiovasculair-kidney-metabool syndroomTaiwan
-
Children's Oncology GroupNational Cancer Institute (NCI)VoltooidStadium I Nier Wilms-tumor | Stadium II Kidney Wilms-tumor | Stadium III Kidney Wilms-tumor | Stadium IV Kidney Wilms-tumor | Volwassen Nier Wilms-tumor | Beckwith-Wiedemann-syndroom | Kidney Wilms-tumor | Diffuse hyperplastische perilobar nefroblastomatose | Rhabdoïde tumor van de nier | Stadium V Kidney...Verenigde Staten, Canada, Australië, Nieuw-Zeeland, Puerto Rico, Israël
-
Children's Oncology GroupNational Cancer Institute (NCI)VoltooidTerugkerend nierneoplasma bij kinderen | Stadium I Nier Wilms-tumor | Stadium II Kidney Wilms-tumor | Stadium III Kidney Wilms-tumor | Stadium IV Kidney Wilms-tumorVerenigde Staten
-
Yaqrit LtdKing's College Hospital NHS Trust; University College, London; Royal Free Hospital... en andere medewerkersNog niet aan het wervenLevercirrose | Acute-on-chronic leverfalen (ACLF)
-
Camille N. Kotton, MDKamada, Ltd.; University of Texas Southwestern Medical CenterWervingCytomegalovirus | Niertransplantatie; complicaties | Orgaan transplantatie | Levertransplantatie complicaties | Gelijktijdige lever-kidney transplantatie; ComplicatiesVerenigde Staten
-
Children's Oncology GroupNational Cancer Institute (NCI)WervingStadium II Kidney Wilms-tumor | Stadium III Kidney Wilms-tumor | Stadium IV Kidney Wilms-tumor | Terugkerende Nier Wilms-tumor | Anaplastische Nier Wilms-tumorVerenigde Staten, Canada, Puerto Rico, Australië, Nieuw-Zeeland, Saoedi-Arabië
Klinische onderzoeken op Active KT intervention
-
Maastricht University Medical CenterB. Braun/Aesculap SpineVoltooidVerplaatsing van de tussenwervelschijf | DiskectomieNederland
-
Universidad Complutense de MadridOnbekendAtletische prestatieSpanje
-
Sunnybrook Health Sciences CentreScarborough General Hospital; Michael Garron Hospital; York Central Hospital, Ontario en andere medewerkersVoltooid
-
Kymera Therapeutics, Inc.VoltooidAtopische dermatitis | Gezonde vrijwilliger | Hidradenitis suppurativaVerenigde Staten
-
Kymera Therapeutics, Inc.VoltooidAtopische dermatitisVerenigde Staten
-
Fundacion para la Investigacion Biomedica del Hospital...Voltooid
-
Kymera Therapeutics, Inc.VoltooidGeavanceerde solide tumoren | Acute lymfatische leukemie | Lymfomen | Myeloïde maligniteitenVerenigde Staten
-
Dignitas InternationalUnity Health TorontoVoltooid
-
Universidad Europea de MadridOnbekend
-
Kymera Therapeutics, Inc.WervingGezonde deelnemersVerenigde Staten